Detalhe da pesquisa
1.
Long-term use of lenalidomide and low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: MM-024 Extended Access Program.
BMC Cancer
; 16: 46, 2016 Jan 28.
Artigo
Inglês
| MEDLINE | ID: mdl-26821931
2.
Continuous lenalidomide treatment for newly diagnosed multiple myeloma.
N Engl J Med
; 366(19): 1759-69, 2012 May 10.
Artigo
Inglês
| MEDLINE | ID: mdl-22571200
3.
ATG-101 Is a Tetravalent PD-L1×4-1BB Bispecific Antibody That Stimulates Antitumor Immunity through PD-L1 Blockade and PD-L1-Directed 4-1BB Activation.
Cancer Res
; 84(10): 1680-1698, 2024 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38501978
4.
Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial.
Haematologica
; 98(5): 784-8, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23242595
5.
Phase I study of single-agent CC-292, a highly selective Bruton's tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia.
Haematologica
; 101(7): e295-8, 2016 07.
Artigo
Inglês
| MEDLINE | ID: mdl-27151992
6.
Population Pharmacokinetics and Exposure Response Assessment of CC-292, a Potent BTK Inhibitor, in Patients With Chronic Lymphocytic Leukemia.
J Clin Pharmacol
; 57(10): 1279-1289, 2017 10.
Artigo
Inglês
| MEDLINE | ID: mdl-28543084
7.
Validation of in vivo pharmacodynamic activity of a novel PDGF receptor tyrosine kinase inhibitor using immunohistochemistry and quantitative image analysis.
Mol Cancer Ther
; 4(8): 1198-204, 2005 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-16093435
8.
Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter double-blinded randomized phase II trial.
Leuk Lymphoma
; 57(6): 1291-9, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-26763349
9.
(6,7-Dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamines: platelet-derived growth factor receptor tyrosine kinase inhibitors with broad antiproliferative activity against tumor cells.
J Med Chem
; 48(26): 8163-73, 2005 Dec 29.
Artigo
Inglês
| MEDLINE | ID: mdl-16366598
10.
Ornithine-δ-Aminotransferase Inhibits Neurogenesis During Xenopus Embryonic Development.
Invest Ophthalmol Vis Sci
; 56(4): 2486-97, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25783604
11.
Lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma and renal impairment.
Int J Hematol
; 101(6): 569-77, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25753225
12.
Multiplexed RT- PCR for high throughput screening applications.
Comb Chem High Throughput Screen
; 7(8): 727-32, 2004 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-15578934
13.
Gene expression analysis for high throughput screening applications.
Comb Chem High Throughput Screen
; 7(2): 133-40, 2004 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-15032660
14.
Factors that influence health-related quality of life in newly diagnosed patients with multiple myeloma aged ≥ 65 years treated with melphalan, prednisone and lenalidomide followed by lenalidomide maintenance: results of a randomized trial.
Leuk Lymphoma
; 55(7): 1489-97, 2014 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-24144308
15.
A multicenter, open-label, phase 2 study of lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: the MM-021 trial.
J Hematol Oncol
; 6: 41, 2013 Jun 19.
Artigo
Inglês
| MEDLINE | ID: mdl-23782711
16.
Cloning, expression, and functional characterization of human cyclooxygenase-1 splicing variants: evidence for intron 1 retention.
J Pharmacol Exp Ther
; 315(3): 1298-305, 2005 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-16141368
17.
Matrix metalloproteinase(s) mediate(s) NO-induced dissociation of beta-catenin from membrane bound E-cadherin and formation of nuclear beta-catenin/LEF-1 complex.
Carcinogenesis
; 23(12): 2119-22, 2002 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-12507936